The discovery of increased lupus anticoagulant after pregnancy requires determining whether the patient has a problem with SLE and antiphospholipid antibody syndrome.
Lupus anticoagulant is an autoimmune antibody specific to SLE patients, and lupus anticoagulant is involved in the blood clotting process. For SLE patients with increased lupus anticoagulant, most of the tests for antinuclear antibody are negative, and the clinical manifestations are atypical, and recurrent spontaneous miscarriages with antiphospholipid antibody syndrome may occur.
For patients with positive lupus anticoagulant, it is recommended to first confirm the presence of lupus erythematosus, confirm lupus erythematosus, but also to assess the presence of lupus nephritis and other problems, to assess whether there is any functional damage to multiple organs, and to determine whether the patient has a tendency to spontaneous abortion.
Patients with increased lupus anticoagulant positivity are seen in the rheumatology department of a regular hospital, especially if they are pregnant, and require a consultation between the rheumatology department and the gynecology department.